Health Condition 1: J069- Acute upper respiratory infection,unspecified Health Condition 2: I10- Essential (primary) hypertension Health Condition 3: R69- Illness, unspecified Health Condition 4: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation Health Condition 5: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Cases attending the General Medicine OPD Patients belonging to any gender Patients above the age of 18 years Patients willing to give written informed consent
Exclusion criteria
Exclusion criteria: Prescriptions containing only non-pharmacological advices Emergency or inpatient prescriptions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average Number of Drugs per EncounterTimepoint: 12 months from the date of approval from Ethics Committee | — |
Secondary
| Measure | Time frame |
|---|---|
| Commonly prescribed drug classes Demographic distribution of patients with respect to age and gender Polypharmacy trends and their clinical relevance Percentage of prescriptions with the occurrence of Adverse Drug Reactions if any recorded from spontaneous patient follow-ups Causality of the ADRs using the WHO UMC scale and NARANJO ADR scale Severity of the ADRs using the modified Hartwig and Siegel scale Pharmacoeconomics of the prescribed drugs with respect to the cost per prescription Timepoint: 12 months from the date of approval from Ethics Committee | — |
Countries
India
Contacts
Public ContactDr ANSHAD YOOSEF K
Government Medical College Palakkad
Outcome results
None listed